The HORMA domain is a highly conserved proteinprotein interaction module found in eukaryotic signaling proteins including the spindle assembly checkpoint protein Mad2 and the meiotic HORMAD proteins. HORMA domain proteins interact with short 'closure motifs' in partner proteins by wrapping their C-terminal 'safety belt' region entirely around these motifs, forming topologically-closed complexes. Closure motif binding and release requires large-scale conformational changes in the HORMA domain, but such changes have only been observed in Mad2. Here, we show that Saccharomyces cerevisiae Hop1, a master regulator of meiotic recombination, possesses conformational dynamics similar to Mad2. We identify closure motifs in the Hop1 binding partner Red1 and in Hop1 itself, revealing that HORMA domain-closure motif interactions underlie both Hop1's initial recruitment to the chromosome axis and its self-assembly on the axis. We further show that Hop1 adopts two distinct folded states in solution, one corresponding to the previouslyobserved 'closed' conformation, and a second more extended state in which the safety belt region has disengaged from the HORMA domain core. These data reveal strong mechanistic similarities between meiotic HORMADs and Mad2, and provide a mechanistic basis for understanding both meiotic chromosome axis assembly and its remodeling by the AAA+ ATPase Pch2/TRIP13.
INTRODUCTION
Meiosis is a specialized two-stage cell division program that gives rise to haploid gametes in sexually reproducing organisms. After a single round of DNA replication, homologous chromosomes segregate from one another in meiosis I, and sister chromosomes subsequently segregate in meiosis II. The extended prophase of meiosis I, in which homologs identify and physically associate with one another through a modified homologous recombination pathway, is governed by a conserved meiosis-specific protein assembly called the chromosome axis. The axis organizes each pair of sister chromosomes as a linear array of chromatin loops and promotes DNA double-strand break (DSB) formation by the conserved Spo11 endonuclease (1, 2) . After DSB formation, axis proteins suppress repair of these DSBs via the nearby sister chromosome, thereby promoting repair via the homolog (3) (4) (5) (6) (7) (8) . This preference is key for the formation of crossovers (COs) that enable homologs to bi-orient on the meiosis I spindle, then properly segregate from one another to reduce ploidy by half. In late prophase, the synaptonemal complex assembles along the length of paired homologs' chromosome axes, bringing the homologs into close juxtaposition and promoting the final steps of crossover formation (reviewed in (9, 10) ). In many organisms including the budding yeast Saccharomyces cerevisiae, plants, and mammals, synaptonemal complex assembly is coordinated with remodeling of the chromosome axis (11) (12) (13) (14) . By depleting CO-promoting factors from homolog pairs that have properly associated, this axis remodeling process constitutes a feedback mechanism governing CO levels on a perchromosome basis (15, 16) .
The chromosome axis is highly conserved in eukaryotes. Major axis components include cohesin complexes containing at least one meiosis-specific subunit, the kleisin Rec8 (17) (18) (19) (20) (21) ; one or more proteins of the meiotic HORMAdomain containing (HORMAD) protein family (discussed further below); and in most organisms a coiled-coil domaincontaining 'linker' protein (S. cerevisiae Red1, S. pombe Rec10, mammalian SYCP2/SYCP3 and plant ASY3) required for localization of HORMADs (22) (23) (24) (25) (26) (27) (28) . In the budding yeast S. cerevisiae, the axis comprises Rec8-containing cohesin complexes and the HORMAD protein Hop1, plus the linker protein Red1 (28) (29) (30) (31) (32) . In wild-type cells, Red1's distribution on chromosomes largely mirrors that of meiotic cohesin complexes (31) , suggesting that Red1 may associate directly with cohesins. Red1 has also been shown to bind directly to Hop1 both in vitro and in cells (24, 33) , and is required for normal chromosome localization of Hop1 (28, 31) , suggesting a hierarchical cohesin→Red1→Hop1 axis assembly mechanism. Hop1, Red1, and Rec8 are all required for normal numbers and spatial distribution of meiotic DSBs (34) (35) (36) , acting at least in part to recruit the Rec114:Mei4:Mer2 complex to the chromosome axis (29) . These proteins are, in turn, required for Spo11 recruitment to the axis and for DSB formation (37) (38) (39) (40) (41) (42) . After DSBs have formed, Hop1 is phosphorylated by the DNA damage-response kinases Mec1 and Tel1 (homologs of mammalian ATM and ATR) in its SCD region (SQ/TQ Cluster Domain), particularly residues S298 and T318 (5, 43) . This phosphorylation promotes the recruitment and activation of the Mek1 kinase, which biases repair of DSBs toward the homolog instead of the sister chromosome, thereby generating COs (6, (44) (45) (46) . After CO designation and the initiation of synaptonemal complex assembly, Hop1 is thought to be removed from the chromosome axis through the action of the conserved AAA+ ATPase Pch2 (13, 47, 48) . As chromosome-localized Hop1 promotes both DSB and CO formation, its removal constitutes a feedback mechanism suppressing further recombination on chromosomes/regions that have already obtained COs (13, 49) . Many of Hop1's regulatory functions are shared by its orthologs in other eukaryotes, including promoting DSBs and biasing their repair toward the homolog, and removal from the chromosome axis by Pch2 (TRIP13 in mammals) in coordination with synaptonemal complex assembly (11, 14, (50) (51) (52) .
Hop1 is the founding member of the meiotic HORMAD protein family, which also includes S. pombe Hop1, plant ASY1/ASY2, mammalian HORMAD1/HORMAD2 and Caenorhabditis elegans HIM-3/HTP-1/HTP-2/HTP-3 (11, 27, 50, (53) (54) (55) (56) . The meiotic HORMADs share a peptide-binding domain termed the HORMA domain, named for three functionally-diverse protein families originally shown to share it: Hop1, Rev7 and Mad2 (57, 58) . The best-understood HORMA domain protein is Mad2, a key regulator of the mitotic spindle assembly checkpoint. This checkpoint monitors kinetochore-microtubule attachments in mitosis and meiosis, and delays anaphase onset until all kinetochores are properly attached to spindle microtubules (59) (60) (61) . The Mad2 HORMA domain can adopt two distinct stably folded conformations, termed 'open' (O-Mad2) and 'closed' (C-Mad2) (62) (63) (64) . In the closed conformation, Mad2 binds short peptides called 'Mad2-interacting motifs' (MIMs) or, more generally, 'closure motifs' (65) (66) (67) . The two conformations of Mad2 differ mainly in the location and conformation of its C-terminal 'safety belt' region: in O-Mad2, this region is stably folded against the closure motif binding site (␤-strand 6), preventing closure motif binding (68) . In C-Mad2, the safety belt is disengaged from this site, allowing a closure motif to bind strand ␤6. The safety belt in turn translocates to the opposite side of the HORMA domain (strand ␤5), wrapping around the ligand to create a topological link between HORMA domain and closure motif (66, 67, 69) . Coupled to safety belt motions are changes in the domain's N-terminus: in O-Mad2, the N-terminus associates with strand ␤5 to stabilize the open conformation. In C-Mad2, however, this region dissociates from the HORMA domain core and is mostly disordered. In the spindle assembly checkpoint, Mad2 is recruited to unattached kinetochores via a closure motif on its binding partner Mad1 (67, 70) . This C-Mad2 in turn recruits soluble O-Mad2, forming a pseudo-symmetric C-Mad2:O-Mad2 dimer via a conserved surface opposite the closure motif binding site (69, 71) . Mad2 dimerization promotes conversion of O-Mad2 to the closed state and binding to a closure motif in Cdc20, to form the core of the mitotic checkpoint complex (72) (73) (74) . Conformational conversion of Mad2 is believed to involve a transient high-energy state in which the safety belt has dissociated from the HORMA domain core, which allows closure motif binding followed by safety belt re-association to produce the C-Mad2:Cdc20 complex (62, 63, 75) . Recently, Pch2/TRIP13 has also been implicated in the spindle assembly checkpoint pathway, acting with an adapter protein, p31 comet , to disassemble the MAD2:Cdc20 complex upon checkpoint silencing (76) (77) (78) (79) (80) (81) (82) .
The close evolutionary relationship between Mad2 and the meiotic HORMADs, plus the involvement of a shared ATPase regulator, Pch2/TRIP13, strongly suggests mechanistic commonalities between these two protein families. Recently, we showed that the C. elegans meiotic HORMADs interact through association of their N-terminal HORMA domains with conserved closure motifs at their Ctermini, and that the resulting hierarchical complex is essential for proper regulation of CO formation and chromosome segregation (83) . We further identified closure motifs in the C-termini of the mammalian meiotic HORMADs, and demonstrated binding of these motifs to the HORMAD1 HORMA domain (83) . In S. cerevisiae, prior genetic evidence has demonstrated the importance of both its Nterminal HORMA domain and a short, highly-conserved C-terminal region (46, 84, 85) . These features, plus additional evidence of Hop1 self-association in vitro (86) , suggest that Hop1 may also self-assemble through HORMA domain-closure motif interactions. Importantly, there is currently no evidence for homodimerization of meiotic HORMADs (58) , suggesting that these proteins' assembly mechanisms are distinct from those of Mad2. Thus, the question of how meiotic HORMADs' HORMA domain conformation and closure motif binding activities are controlled remains an important question. Specifically, as meiotic HORMADs have only been observed in their closed, closure-motif bound conformation, it is not known whether they adopt an 'open' conformation similar to Mad2 during closure motif binding and dissociation. Indeed, no HORMA domain protein other than Mad2 has been shown to possess the conformational dynamics that would seem to be necessary for assembly and disassembly of HORMA domain-closure motif complexes. Another major question is how meiotic HORMADs are initially recruited to the chromosome axis by coiled-coil 'linker' proteins such as Red1, and whether this recruitment also involves HORMA domain-closure motif interactions.
Here, we present a detailed biophysical characterization of the S. cerevisiae Hop1 HORMA domain. We identify related motifs in the Hop1 C-terminus and in Red1 that bind the Hop1 HORMA domain, indicating that HORMA domain-closure motif interactions are responsible for both initial localization and self-assembly of Hop1 on the chromosome axis. We further find that the Hop1 HORMA domain displays conformational dynamics reminiscent of Mad2, and identify a new conformation of Hop1, termed 'unbuckled', that likely functions analogously to open Mad2. These results outline the assembly mechanisms of the meiotic chromosome axis and reveal a close structural and functional relationship between the meiotic HORMADs and Mad2.
MATERIALS AND METHODS

Protein expression and purification
Structural modeling. An initial structural model of the Hop1 HORMA domain was generated using the One-toOne Threading mode of the PHYRE2 server (http://www. sbg.bio.ic.ac.uk/~phyre2/) using C. elegans HTP-1 (PDB ID 4TZO, chain C) as a template (83) • C for 16 h, then cells were harvested by centrifugation and resuspended in buffer A (20 mM Tris pH 8.5, 10% glycerol) plus 300 mM NaCl, 10 mM imidazole and 2 mM ␤-mercaptoethanol. Protein was purified by Ni 2+ -affinity (Ni-NTA agarose, Qiagen) and ion-exchange (Hitrap Q HP, GE Life Sciences, Piscataway, NJ, USA) chromatography. Tags were cleaved with TEV protease (87) , and cleaved protein was passed over a size exclusion column (Superdex 200, GE Life Sciences) in buffer A plus 300 mM NaCl and 1 mM dithiothreitol (DTT). Full-length Hop1 (wild-type and K593A), Hop1 584 , and Red1 2-362 were purified as above, but at pH 7.5 instead of 8.5.
For size-exclusion chromatography coupled multi-angle light scattering (SEC-MALS), proteins were separated on a Superdex 200 Increase 10/300 GL size exclusion column (GE Life Sciences) in a buffer containing 20 mM HEPES pH 7.5, 300 mM NaCl, 10% glycerol, and 1 mM DTT. Absorbance was measured at 280 nm, and light scattering and refractive index profiles collected by miniDAWN TREOS and Optilab T-rEX detectors (Wyatt Technology, Santa Barbara, CA, USA), respectively, and their molecular weights calculated using ASTRA v. 6 software (Wyatt Technology). For size-exclusion chromatography +/-Red1 345-362 peptide, proteins were pre-incubated with a 2-fold molar excess of Red1 345-362 peptide for 30 min at 4
• C, then separated on a Superdex 200 Increase 10/300 GL size exclusion column in a buffer containing 20 mM MES pH 6.0, 300 mM NaCl, 10% glycerol, and 1 mM DTT.
Protein interaction assays.
Putative closure motifs in Hop1 (residues 584-605) and Red1 (residues 330-362), along with point-mutants, were cloned into a pET3a-based vector with an upstream Kozak sequence and N-terminal maltose binding protein (MBP) tag, and translated in vitro with a TNT T7 Transcription/Translation kit (Promega) with 35 S-methionine. Ni 2+ pulldown assays were performed with C-terminally His 6 -tagged Hop1 . 10 g purified bait protein was incubated with 10 l of the translation reaction in binding buffer (20 mM HEPES, pH 7.5, 150 mM NaCl, 20 mM imidazole, 5% glycerol, 1 mM dithiothreitol (DTT), 0.1% NP-40) for 90 min at 4
• C, then 15 l Ni-NTA beads were added, and the mixture was incubated a further 45 min. Beads were washed three times with 0.5 ml buffer, then eluted with 25 l elution buffer (2× SDS-PAGE loading dye plus 400 mM imidazole) and boiled. Samples were run on SDS-PAGE, then the gel was dried and scanned with a phosphorimager. 2-255 LL) in binding buffer (20 mM HEPES pH 7.5, 300 mM NaCl, 10 mM imidazole, 10% glycerol, 1 mM DTT, 0.1% NP-40) were incubated 2 hours at room temperature. Samples were then mixed with 20 ul of magnetic Ni-NTA beads (5% suspension; Qiagen) and incubated with rotation for 30 min. Beads were washed three times with 0.5 ml binding buffer, eluted with 25 l of elution buffer (2x SDS-PAGE loading dye plus 400 mM imidazole) then boiled. Samples were analyzed by SDS-PAGE, and visualized by Coomassie Blue staining.
For fluorescence polarization peptide binding assays, FITC-labeled peptides (BioMatik) at 50 nM were incubated with 12 nM-100 M Hop1 2-255 or Hop1 2-255 LL in 50 l binding buffer for 30 min, then transferred to a 384-well black plate. Fluorescence polarization of triplicate reactions were read using a Tecan Infinite M1000 PRO fluorescence plate reader, and binding data were analyzed with Graphpad Prism v.6 using a single-site binding model.
Hydrogen-deuterium exchange mass spectrometry. HD exchange experiments were conducted with a Waters Synapt G2S system. 5 ul samples in exchange buffer (20 mM HEPES pH 7.5, 300 mM NaCl, 10% glycerol) were mixed with 55 l of D 2 O buffer for several deuteration times (10 s, 30 s, 1 min, 2 min, 5 min) at 15
• C. The exchange was quenched for 2 min at 1
• C with an equal volume of quench buffer (200 mM iodoacetic acid (IAA), 400 mM Tris-HCl pH 8.5, 6.2 M urea, 2 mM EDTA). A portion of the quenched sample (50 l) was injected onto an inline pepsin column (Applied Biosystems, Poroszyme Immobilized Pepsin cartridge). The resulting peptic peptides were then separated on a C18 column (Waters, Acquity UPLC BEH C18, 1.7 m, 1.0 mm × 50 mm) fit with a Van-guard trap column using a 3-85% acetonitrile (containing 0.1% formic acid) gradient over 12 min at a flow rate of 40 l/min. The separated peptides were directed into a Waters SYNAPT G2s quadrupole time-of-flight (qTOF) mass spectrometer. The mass spectrometer was set to collect data in the MSE, ESI+ mode; in a mass acquisition range of m/z 255.00−1950.00; with a scan time of 0.4 s. Continuous lock mass correction was accomplished with infusion of the LeuEnk peptide every 30 s (mass accuracy of 1 ppm for the calibration standard). Peptides were identified using PLGS version 2.5 (Waters, Inc.). The relative deuterium uptake for each peptide was calculated by comparing the centroids of the mass envelopes of the deuterated samples with the undeu-terated controls using DynamX version 2.0 (Waters Corp.).
For analysis of peptides showing bimodal HD exchange behavior, assigned peaks for spectra collected at the 5-min time-point were exported as mass/charge versus intensity, normalized to a maximum intensity of 1.0 for each spectrum, and triplicate samples were fit in Graphpad Prism (version 6; Graphpad Software) to either a single Gaussian distribution:
where Amplitude is the amplitude, Mean is the mean, and StDev is the standard deviation of the function, or a sum of two Gaussian distributions: 
RESULTS
Hop1 and Red1 possess similar Hop1 HORMA domainbinding 'closure motifs'
To better understand the functional parallels between S. cerevisiae Hop1 and its orthologs in C. elegans and mammals, we first sought to determine if Hop1 self-assembles through interactions between its N-terminal HORMA domain and a C-terminal closure motif (83) . Sequence alignments show that fungal Hop1 proteins share a highly conserved C-terminal Domain (CTD) of ∼20 amino acids (Figure 1A) . Prior work has shown that deletion of the Cterminal 20 residues of Hop1, or mutation of the highlyconserved 'KIS' motif spanning residues 593-595 (K593A or S595N) dramatically reduces meiotic DSB and CO numbers and causes high spore lethality, indicating an important role for this domain in Hop1 function (46, 85, 88) . We noticed that the Hop1 C-terminus bears limited sequence homology with a region of Red1 previously shown to interact directly with Hop1, notably including a 'KIS' motif spanning Red1 residues 348-350 ( Figure 1A ) (24) . Further, a Red1 K348E mutant has previously been shown to eliminate its ability to bind Hop1, leading to reduced COs, defective homolog synapsis, and low spore viability (24) . Together, the similarity of these motifs and their importance for axis structure and function suggest that both Hop1 and Red1 contain closure motifs that bind the Hop1 HORMA domain. We defined the HORMA domain of S. cerevisiae Hop1 by modeling the structure of this domain onto on our prior structure of C. elegans HTP-1 (15% identity and 35% similarity to Hop1 in this domain) ( Figure 1B, Supplementary  Figure S1 ). We expressed and purified an isolated Hop1 HORMA domain construct (Hop1 2-255 ), and showed that this truncated construct as well as full-length Hop1 robustly bind purified Red1 , which encompasses the conserved N-terminal domain of this protein plus the region previously shown to interact with Hop1 (Supplementary Figure  S2) . Because of high protease-sensitivity of purified fulllength Red1, we were unable to demonstrate a direct interaction between purified full-length Hop1 and Red1 proteins.
We next tested binding of Hop1 (Figure 2A) . In both cases, binding was abolished by point-mutations in the peptides based on previously identified mutations, Hop1 K593A and Red1 K348E (Figure 2A ) (46) . We next used a Ni 2+ pulldown assay with His 6 -tagged Hop1 and in vitro-translated Hop1 584-605 or Red1 345-362 (produced as maltose binding protein fusions). As in the prior assays, we observed binding of the Hop1 HORMA domain to both peptides, that was disrupted by mutation of the conserved lysine residue in the 'KIS' motif (Hop1 K593A/Red1 K348E) ( Figure  2B ). Moreover, binding of Hop1 584-605 to Hop1 2-255 was disrupted by addition of a two-fold molar excess of unlabeled Red1 345-362 peptide, revealing that the two putative closure motifs compete for a common binding site on the Hop1 HORMA domain ( Figure 2B ). Together, these data strongly suggest that Red1 and Hop1 possess similar HORMA domain-binding closure motifs. Further, Hop1 likely shares the propensity to self-associate through HORMA domain-CTD binding with its orthologs in C. elegans and mammals. When combined with prior data showing that the hop1-K593A mutation causes an 11-fold reduction in COs and results in high spore lethality (46) , our data argues that Hop1 self-association at the meiotic chromosome axis is critically important for its regulatory functions.
As the Hop1 protein possesses a putative closure motif on its own C-terminus, this motif might be expected to compete for binding to peptides added in trans. To test this idea, we expressed and purified full-length Hop1, as well as variants with either the K593A mutation (Hop1 K593A ) or with residues 585-605 in the CTD deleted (Hop1 584 ), and tested their binding to the Red1 Figure 2C ). Together, these data suggest that while Hop1's own CTD does compete with a Red1 peptide added in trans for HORMA domain binding, the higher affinity of Red1 for the Hop1 HORMA domain nonetheless likely enables Red1 to recruit full-length Hop1 directly to the chromosome axis.
The Hop1 HORMA domain adopts two distinct conformations in solution
During the purification of Hop1 2-255 , we noticed that the protein elutes from a size-exclusion column as two closelyspaced peaks, one with an elution volume consistent with a compact monomer and the other consistent either with a dimer or an extended monomer ( Figure 3A) . Further analysis by size exclusion chromatography coupled to multi-angle light scattering ( Figure 3B) showed that both peaks contain monomeric Hop1 , demonstrating that the domain can likely adopt two different conformations in solution: one compact, and one more extended. We wondered how these two conformations of Hop1 2-255 might relate to the previously-described 'closed' and 'open' states of Mad2. We found that pre-incubation of Hop1 2-255 with the Red1 peptide shifted the equilibrium toward the later-eluting, more-compact size exclusion peak ( Figure 3A ). This finding suggests that the more-compact peak represents 'closed' Hop1 HORMA domain, and that the earlier-eluting, lesscompact peak represents a second, potentially open-like conformation. Consistent with the idea that the HORMA domain of full-length Hop1 can associate with its own Cterminal tail, we fund that full-length Hop1 elutes from a size-exclusion column as a monomer ( Figure 3B ). To further examine the conformational differences between the two states of the Hop1 HORMA domain, we generated several Hop1 2-255 variants based on mutations known to stabilize either the open or closed conformation of Mad2 (66, 89, 90) , and examined their behavior in solution. While most variants destabilized Hop1 2-255 , one markedly improved expression and stability of the protein. This mutant, referred to as 'loopless' or Hop1 LL (residues 135-158 replaced by a Gly-Ser-Gly linker), is based on the Mad2 'loopless' construct in which the extended ␤5-␣C loop is replaced by a short linker (69) . This mutation is thought to inhibit O-Mad2 to C-Mad2 conversion by preventing dissociation of the protein's N-terminus from the ␤5 strand, thereby disallowing safety belt movement and conversion to the C-Mad2 state. The structural effect of this mutant in Hop1 is difficult to predict, as the ␤5-␣C loop is longer and more well-ordered in meiotic HORMADs than in Mad2, draping over the safety belt ␤-strands 8 and 8 ( Figure 1B) (83) . We found that in contrast to wild-type Hop1 2-255 , Hop1 2-255 LL migrated as a single species on a size-exclusion column consistent with a compact monomer, and that its elution profile was mostly unaffected by addition of the Red1 330-362 peptide ( Figure 3A, B) . We next tested binding of Hop1 LL to the putative closure motif peptides Hop1 584-605 and Red1 345-362 , and found that the mutated protein robustly binds both peptides; indeed, the loopless mutation seems to subtly increase peptide binding affinity compared to unmutated Hop1 2-255 ( Figure 3C ). As the putative closure-motif binding site of Hop1 is not altered in this mutant, we interpret this slightly-increased affinity as indicating that the loopless mutation stabilizes the peptide-binding conformation of the Hop1 HORMA domain; namely, the 'closed' conformation.
Conformational dynamics of the Hop1 HORMA domain revealed by hydrogen-deuterium exchange mass spectrometry
We next sought further structural insight into the relationship between Hop1 HORMA domain conformation and peptide binding. As we were unable to identify crystallization conditions for the Hop1 HORMA domain or its complex with the Red1 closure motif, and low expression levels prevented examination by NMR, we instead turned to hydrogen-deuterium exchange mass spectrometry (HDX-MS). In HDX-MS, exchange of backbone amide hydrogen atoms with deuterium from D 2 O-containing buffer provides information on the solvent-accessibility and secondary structure of different regions of a protein. We detected mass spectra for a set of common peptides in Hop1 2-255 and Hop1 2-255 LL (covering 61% and 70% of the two constructs, respectively), including the C-terminal safety belt region but notably excluding the ␤5-␣C loop (deleted in the Hop1 LL mutant, and not detected in Hop1 ) and the N-terminus (Supplementary Figure S3A  and B) . The rates of deuterium uptake in different regions largely agreed with predicted secondary structure in our model of the Hop1 HORMA domain based on C. elegans HTP-1 in the 'closed' conformation (Supplementary Figure  S3C and D) (83) . This was especially true for Hop1 2-255 LL, which our size-exclusion chromatography analysis shows adopts exclusively the more-compact conformation.
We next compared HDX-MS profiles of Hop1 Figure 4A , D, E). Residues 91-99 in helix ␣B, which is positioned just behind the closure motif binding site, as well as residues 74-90 in the ␤2-␤3 hairpin adjacent to helix ␣B, also show a high degree of protection upon Red1 345-362 binding ( Figure 4B  and E) . Finally, we also observed significant protection in regions corresponding to the ␤8 and ␤8 strands of the safety belt (residues 234-248), as well as helix ␣C (residues 164-173), which packs against these ␤-strands in the closed HORMA domain conformation ( Figure 4C and E) . Significant protection of the safety belt and adjacent regions upon binding of Red1 345-362 strongly suggests that the two Hop1 conformations we observe in solution differ largely in the conformation of the safety belt, consistent with the known conformational changes of Mad2.
In Hop1 2-255 LL, H-D exchange rates for most regions, including peptides within and adjacent to the safety belt (residues 165-173 and 234-248), are much less affected by the addition of Red1 345-362 than in wild-type Hop1 2-255 , supporting the idea that this mutant pre-forms the morecompact closed conformation in the absence of closure motif peptides ( Figure 4C, Supplementary Figure S4B) . Notable exceptions include residues 182-195 and 198-211, which make up the putative closure motif binding site: these regions would be expected to show different H-D exchange rates based on closure motif binding alone ( Figure 4A and F). Thus, Hop1 2-255 LL likely adopts an 'empty' closed conformation, to which closure motif peptides can directly associate without HORMA domain conformational conversion.
Our size-exclusion chromatography data showed that in the absence of a bound peptide, Hop1 2-255 adopts two different conformations in solution. Consistent with this finding, a number of peptides in the Hop1 2-255 construct show a bimodal distribution of H-D exchange rates (Figure 5) . Bimodal H-D exchange rate distributions arise when the region in question can stably adopt two differently solvent-exposed conformations, resulting in highexchanging (more solvent-exposed) and low-exchanging (less solvent-exposed) populations. The regions showing the most pronounced bimodality include residues 234-248, spanning ␤8 and ␤8 in the safety belt ( Figure 5B ), residues 164-173 in the adjacent ␣C-helix ( Figure 5C ), and residues 40-49 and 74-90 in the ␤2-␤3 hairpin ( Figure  5D-F) . These peptides' bimodal behavior is nearly eliminated in the presence of the Red1 345-362 peptide, and they all show a monomodal H-D exchange rate distribution in Hop1 2-255 LL regardless of Red1 345-362 binding ( Figure 5A -C). Taken together, our HDX-MS data as a whole supports our identification of two stable conformations of the Hop1 HORMA domain, and suggest that the two states differ largely in the conformation of the domain's C-terminal safety belt region. While the strong bimodality in H-D exchange rates in these regions of wild-type Hop1 shows that this construct populates both states in solution, addition of the Red1 345-362 peptide shifts the equilibrium strongly in favor of the 'closed' conformation ( Figure 5G ).
Hop1
2-255 LL shows a strong bias toward the closed state on its own, which is further shifted toward this state upon binding the Red1 345-362 peptide.
DISCUSSION
In this study, we present a combined biochemical and biophysical characterization of the S. cerevisiae meiotic HORMA domain protein Hop1, identifying Hop1-binding closure motifs in both Hop1 and its binding partner Red1, and characterizing two distinct conformations of the Hop1 HORMA domain. When combined with prior genetic data, our results strongly suggest that HORMA domain-closure motif interactions underlie both the initial association and self-assembly of Hop1 on meiotic chromosomes. As both C. elegans and mammalian meiotic HORMADs self-assemble through HORMA domain-closure motif interactions (83), and most eukaryotes possess a Red1-like 'linker' protein required for axis assembly, our results suggest that initial association of meiotic HORMADs with meiotic chromosomes may also be mediated by HORMA domain-closure motif interactions. In C. elegans, our earlier work suggested that HTP-3 may bind directly to a subunit of the cohesin complex (83) . Mammalian HORMAD1 and HORMAD2 may also bind cohesin complexes directly, or alternatively bind a closure motif in SYCP2 or SYCP3, in a parallel of the Hop1-Red1 association (22, 91) . Our data suggest that Hop1 initially binds chromosomes through a closure motif in Red1, followed by additional Hop1 recruitment via head-to-tail oligomerization ( Figure  6A ). The competition we observe between Red1 and Hop1's own C-terminus for binding the HORMA domain suggests that in solution, Hop1 tends to form a 'self-closed' state but that recruitment of Hop1 to the chromosome axis by Red1 displaces the Hop1 CTD from the HORMA domain. This free CTD may in turn bind the HORMA domain of a second Hop1 monomer, initiating multimeric assembly. A conceptual problem with this model is that if the Hop1 HORMA domain can interact with a closure motif at its own C-terminus, the high local concentration of this closure motif would be expected to preclude binding to a second Hop1 monomer in trans. Hop1 oligomerization on the axis would only be favored if steric constraints not present in our reconstituted system were to inhibit self-interaction relative to oligomerization. Such constraints could include posttranslational modifications and/or protein-protein interactions, such as the known phosphorylation of the Hop1 SCD region, which mediates recruitment of the Mek1 kinase (5, 6, 43, 45, 46) . Pch2 may also contribute to Hop1 oligomerization (at least in some systems; see below), but its role is likely to be purely kinetic; that is, Pch2 could generally stimulate Hop1 conformational dynamics, but is unlikely to alter the equilibrium Hop1 oligomer length unless it is specifically localized to chromosomes (see below). While we are not yet able to explain the physical basis for Hop1 oligomerization, the strong effects on DSB and CO levels, homolog synapsis, and overall spore viability observed when mutating or deleting the Hop1 CTD (46, 85) constitute strong indirect evidence that Hop1 oligomerization plays a key role in CO formation. Interestingly, the CO defect caused by a hop1-K593A mutant can be rescued by ectopic dimerization of Mek1, through its fusion to the dimeric glutathione S-transferase protein (46) . This result suggests that one role of Hop1 self-association is to activate Mek1, likely by bringing multiple copies of the kinase into close proximity at the chromosome axis to enable trans-autoactivation ( Figure 6A) . Notably, the defect in both DSB and CO levels in a hop1-K593A strain is significantly less severe than in hop1Δ, and the Hop1 K593A mutant protein behaves well in vitro (this work) and localizes to meiotic chromosomes (46) . These data support the idea that Red1 can recruit Hop1 directly, but that additional Hop1 recruitment through head-to-tail binding is nonetheless required to support wild-type levels of DSB formation and Mek1 kinase activation, which combine to support CO formation.
In addition to the meiotic HORMADs, HORMA domains are found in Mad2, Rev7, and two autophagy-related proteins, Atg13 and Atg101 (57, 65) . While Mad2 has been shown to adopt two stable conformations in solution, similar conformational dynamics have not been observed in any other HORMA domain protein family (65) . Here, we show for the first time that the S. cerevisiae meiotic HORMAD Hop1 can adopt two different stable states in solution: a closed conformation similar to what we previously observed for the C. elegans meiotic HORMADs (83) , and a more extended conformation. Our HDX-MS data indicate that the two states differ mainly in the conformation of the protein's C-terminal safety belt region, and that this region is probably disengaged from the HORMA domain core in the ex- tended state. This model contrasts with Mad2's open conformation, in which the safety belt is stably associated with the closure-motif binding site, generating a structure that is similarly compact to the protein's closed conformation (92) ( Figure 6B ). The extended state of the Hop1 HORMA domain may therefore correspond more closely with the theorized transient Mad2 intermediate state, in which the safety belt has disengaged from the HORMA domain core to allow Cdc20 closure motif binding (62, 69) (Figure 6B ). Because the term 'intermediate' has more recently been used to refer to a compact Mad2 conformation adopted just prior to this conformational change (75), we instead introduce the term 'unbuckled' to refer to a HORMA domain conformation in which the safety belt is stably disengaged from the HORMA domain ( Figure 6C ).
While we designed the Hop1 'loopless' mutation based on a Mad2 variant that stabilizes this protein's open conformation (69) , this mutation appears to stabilize the closed conformation in Hop1. In Mad2, truncation of the ␤5-␣C loop is thought to disallow dissociation of the protein's Nterminal ␤1 strand from strand ␤5 in the HORMA domain core, thereby inhibiting the open-to-closed conformational change (69) . We propose that Hop1 may not possess an Nterminal ␤1 strand, and that the 'unbuckled' conformation is instead stabilized by the extended ␤5-␣C loop itself. As this loop is much longer in meiotic HORMADs than in Mad2 (24 residues in Hop1 versus 9 in Mad2), the loop could bind against ␤5 after safety belt dissociation to stabilize the unbuckled state. In this scheme, truncation of the ␤5-␣C loop would be expected to destabilize the unbuckled state, thereby favoring the closed state as we observe for Hop1 2-255 LL ( Figure 6C ). It is important to note that, while Hop1 2-255 LL binds closure-motif peptides at least as tightly as wild-type Hop1 , this mutant is likely to be strongly defective in vivo. As binding of a closure-motif peptide to an 'empty' closed Hop1 requires that the peptide thread un- derneath part of the safety belt region, binding of the Red1 closure motif (more than 300 amino acids from either terminus of Red1) would be expected to require a conformational change in Hop1, much as in Mad2. We have so far been unable to test the function of Hop1 LL in S. cerevisiae, due to extremely poor expression of the mutant protein in meiotic cells. As Hop1 2-255 LL is more highly expressed in Escherichia coli than the wild-type protein and is extremely stable in solution, the low levels of Hop1 LL we observe in S. cerevisiae may indicate that the protein is unstable, perhaps due to an inability to assemble on meiotic chromosomes.
Our data indicate that in S. cerevisiae, chromosome axis assembly is mediated in large part by binding of the Hop1 HORMA domain to closure motifs in both Hop1 and Red1. In contrast to Mad2, where assembly with Cdc20 occurs specifically at unattached kinetochores through dimerization-catalyzed conformational conversion, we envision meiotic chromosome axis assembly to be largely spontaneous. A major remaining question, however, is how meiotic HORMADs are removed from the chromosome axis by Pch2/TRIP13 in coordination with synaptonemal complex assembly ( Figure 6A) . We have recently shown that mammalian TRIP13 binds the disordered N-terminus of Mad2 and then partially unfolds the protein to mediate the disengagement of the Mad2 safety belt from the HORMA domain core (76, 93) . We further showed that N-terminal truncation of mouse HORMAD1 inhibits its TRIP13-mediated disassembly from meiotic chromosome axes, highlighting a common remodeling mechanism with Mad2 (93). We propose that Pch2/TRIP13 may be important to drive HORMA domain conformational dynamics and closure motif association/dissociation in meiotic HORMADs throughout eukaryotes. In this scheme, synaptonemal complex assembly likely triggers recruitment of Pch2/TRIP13 to the chromosome axis, where it removes HORMADs by disassembling HORMA domainclosure motif interactions. An important question in this regard is whether there exist two pools of meiotic HORMADs on chromosome axes, distinguished by their binding partners: in both S. cerevisiae and mammals, not all Hop1/HORMAD1 is removed from the axis upon synaptonemal complex assembly (11) (12) (13) 28, 94) . This finding, plus the higher affinity of Hop1 for the Red1 closure motif and the location of the Red1 closure motif far from either terminus of this protein, suggests that Pch2 might more effectively disassemble Hop1-Hop1 complexes compared to Hop1-Red1 complexes.
In some systems, notably the rice Oryza sativa, mutation of Pch2/TRIP13 causes a loss of initial association of meiotic HORMADs with the chromosome axis (95) . This observation suggests another potential role of Pch2/TRIP13, that also parallels earlier findings with Mad2. In the spindle assembly checkpoint, a pool of O-Mad2 is required for kinetochore-recruitment and assembly with Cdc20, and TRIP13 is required to maintain this pool of O-Mad2 by converting empty C-Mad2 to the open conformation (76, 96) . In a similar vein, if the meiotic HORMADs in a given organism are much more stable in the closed conformation, Pch2/TRIP13 may be required to stimulate their dynamics to promote initial assembly of the chromosome axis, in addition to its later functions in HORMAD disassembly. Overall, the role of Pch2/TRIP13 in promoting function of meiotic HORMADs, and especially its detailed mechanism of meiotic HORMAD recognition and remodeling, will be an interesting avenue for future research.
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